Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial

Autor: Tyler Forehand, Edward Septimus, Ken Kleinman, Mary K. Hayden, Lauren Shimelman, John A. Jernigan, Jonathan B. Perlin, Julia Moody, Abate Infection trial team, Richard Platt, Robert A. Weinstein, Lena M. Portillo, Jason Hickok, Lauren Heim, Katherine Haffenreffer, Caren Spencer-Smith, Susan S. Huang, Julie Lankiewicz, Michael V. Murphy, Taliser R. Avery, Micaela H Coady, Jalpa Sarup-Patel, Adrijana Gombosev, Rebecca E. Kaganov
Rok vydání: 2019
Předmět:
Male
Bathing
Outcome Assessment
Drug Resistance
Bacteremia
030204 cardiovascular system & hematology
Medical and Health Sciences
law.invention
chemistry.chemical_compound
0302 clinical medicine
Randomized controlled trial
Anti-Infective Agents
law
Drug Resistance
Multiple
Bacterial

Outcome Assessment
Health Care

Infection control
030212 general & internal medicine
education.field_of_study
Chlorhexidine
Bacterial
General Medicine
Staphylococcal Infections
Middle Aged
Intensive Care Units
Infectious Diseases
Mupirocin
Local
Intranasal
Administration
Carrier State
Female
Patient Safety
Infection
Multiple
medicine.drug
Methicillin-Resistant Staphylococcus aureus
medicine.medical_specialty
Staphylococcus aureus
Clinical Trials and Supportive Activities
Population
03 medical and health sciences
Clinical Research
Intensive care
Internal medicine
General & Internal Medicine
medicine
Humans
education
Administration
Intranasal

Aged
Infection Control
business.industry
Prevention
Baths
ABATE Infection trial team
Clinical trial
Health Care
Emerging Infectious Diseases
chemistry
Anti-Infective Agents
Local

Antimicrobial Resistance
business
Zdroj: Lancet (London, England), vol 393, iss 10177
ISSN: 0206-3867
Popis: BACKGROUND:Universal skin and nasal decolonisation reduces multidrug-resistant pathogens and bloodstream infections in intensive care units. The effect of universal decolonisation on pathogens and infections in non-critical-care units is unknown. The aim of the ABATE Infection trial was to evaluate the use of chlorhexidine bathing in non-critical-care units, with an intervention similar to one that was found to reduce multidrug-resistant organisms and bacteraemia in intensive care units. METHODS:The ABATE Infection (active bathing to eliminate infection) trial was a cluster-randomised trial of 53 hospitals comparing routine bathing to decolonisation with universal chlorhexidine and targeted nasal mupirocin in non-critical-care units. The trial was done in hospitals affiliated with HCA Healthcare and consisted of a 12-month baseline period from March 1, 2013, to Feb 28, 2014, a 2-month phase-in period from April 1, 2014, to May 31, 2014, and a 21-month intervention period from June 1, 2014, to Feb 29, 2016. Hospitals were randomised and their participating non-critical-care units assigned to either routine care or daily chlorhexidine bathing for all patients plus mupirocin for known methicillin-resistant Staphylococcus aureus (MRSA) carriers. The primary outcome was MRSA or vancomycin-resistant enterococcus clinical cultures attributed to participating units, measured in the unadjusted, intention-to-treat population as the HR for the intervention period versus the baseline period in the decolonisation group versus the HR in the routine care group. Proportional hazards models assessed differences in outcome reductions across groups, accounting for clustering within hospitals. This trial is registered with ClinicalTrials.gov, number NCT02063867. FINDINGS:There were 189 081 patients in the baseline period and 339 902 patients (156 889 patients in the routine care group and 183 013 patients in the decolonisation group) in the intervention period across 194 non-critical-care units in 53 hospitals. For the primary outcome of unit-attributable MRSA-positive or VRE-positive clinical cultures (figure 2), the HR for the intervention period versus the baseline period was 0·79 (0·73-0·87) in the decolonisation group versus 0·87 (95% CI 0·79-0·95) in the routine care group. No difference was seen in the relative HRs (p=0·17). There were 25 (
Databáze: OpenAIRE